IL6 and COVID-19: Traditionally, activation of the NLRP3 inflammasone is regarded to be the main inducer of pathogenic pro-inflammatory cytokines IL-1β, IL-18 and IL-6 during COVID-19, but it has become clear that multiple non-conical pathways can contribute and indeed become the dominate inducers of IL-1β.